Drawing for SERAVUE

USPTO serial 50090913

SERAVUE

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
—
Law office
—

What this means

Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.

Status 630: Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies.

Need help with SERAVUE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Mike McArthur

Mike McArthur Haynes and Boone, LLP2801 N Harwood Street, Suite 2300Dallas, TX 75201United States

Goods and services

ClassDescriptionStatusFirst use
005Diagnostic reagents for medical use in in vitro diagnosis; Medical diagnostic reagents for use in in vitro diagnosis of liver cancer; Medical diagnostic reagents for use in detection and surveillance of liver cancer; Diagnostic biomarker reagents for medical purposes; Diagnostic reagents for medical use; Diagnostic test reagents for medical use; Diagnostic reagents for medical purposes; Diagnostic test reagents for medical purposes; Reagents for use in diagnostic tests for medical purposes; Biological reagents for medical purposes; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, liver cancer; Diagnostic kits comprising diagnostic agents, preparations and substances for medical use; Diagnostic agents, preparations and substances for medical purposes; Clinical medical reagents; Medical diagnostic reagents; Diagnostic chemical reagents for medical purposes; Chemical reagents for medical purposesACTIVE—
009Downloadable computer software for use in medical diagnostics; Downloadable computer software for analyzing medical data; Downloadable medical software for analysis and interpretation of clinical diagnostic data; Downloadable medical software for analyzing biomarker data for use in medical diagnostics; Downloadable medical software for generating diagnostic reports; Downloadable computer application software for mobile phones and tablet computers, namely, software for integration, analysis, management, and exchange of clinical laboratory and diagnostic data, calculating diagnostic risk scores, longitudinal tracking of patient clinical data, and generating diagnostic reports; Downloadable software in the nature of a mobile application for integration, analysis, management, and exchange of clinical laboratory and diagnostic data, calculating diagnostic risk scores, longitudinal tracking of patient clinical data, and generating diagnostic reportsACTIVE—
042Software as a service (SAAS) services featuring software for analysis and interpretation of clinical diagnostic data; Software as a service (SAAS) services featuring software for calculating diagnostic risk scores; Software as a service (SAAS) services featuring software for statistical analysis of clinical diagnostic data; Software as a service (SAAS) services featuring software for longitudinal tracking and analysis of patient clinical data; Software as a service (SAAS) services featuring software for generating diagnostic reports; Software as a service (SAAS) services featuring software for integration, transmission, and exchange of clinical laboratory and diagnostic data; Providing on-line non-downloadable software using artificial intelligence (AI) for analysis and interpretation of clinical diagnostic data and diagnostic risk scoresACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 4, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 4, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance